In patients with gastroesophageal reflux disease (GERD), esomeprazole, has demonstrated pharmacological and clinical benefits beyond those seen with the other proton pump inhibitors( PPIs ). However ...
October 27, 2011 (Vancouver, British Columbia) — The proton-pump inhibitor (PPI) esomeprazole (Nexium, AstraZeneca) is "at least as bad" as omeprazole in reducing ...
April 10, 2009 (Munich, Germany) — A new study using platelet-aggregometry testing to assess the effects of different proton-pump inhibitors (PPIs) on platelet response to clopidogrel suggests that ...
Prescription_writing Advice of regulatory authorities released in 2009 and 2010 regarding safety concerns for concomitant use of clopidogrel and certain proton pump inhibitors (PPIs) was partially ...
The U.S. Food and Drug Administration has received and is reviewing new safety data about two popular heartburn medications -- Prilosec (omeprazole) and Nexium (esomeprazole). On May 29, 2007, ...
The sulfhydryl agent cysteamine (also known as mercaptamine) is the only available treatment for CYSTINOSIS, but is often associated with compliance-compromising overproduction of gastric acid.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback